1-13 of 13
Veronica MacLeod
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Role of PHF19 As a Promoter of Tumorigenicity and Therapeutic Target in Multiple Myeloma

Carolina D. Schinke, MD, Pingping Qu, Shmuel Yaccoby, PhD, Valeriy V Lyzogubov, MD PhD, Veronica MacLeod, Eileen M Boyle, Randal Shelton, Wen Ling, PhD, Sharmilan Thanendrarajan, MD, Maurizio Zangari, MD, Bart Barlogie, MD PhD, Frits van Rhee, MD PhD, Brian A Walker, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 508.
https://doi.org/10.1182/blood-2019-130595
Published: 2019
Journal Articles

Myeloma-Derived Exosomes and Soluble Factors Suppress Natural Killer Cell Function

Tarun K. Garg, PhD, Jessica I Gann, Priyangi A Malaviarachchi, BS, Kate Stone, BS, Veronica Macleod, Amy D Greenway, Nisreen S Akel, Ricky D Edmondson, PhD, Faith E Davies, MD, Joshua Epstein, DSc, Gareth J Morgan, MD PhD, Frits van Rhee, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2066.
https://doi.org/10.1182/blood.V128.22.2066.2066
Published: 2016
Journal Articles

47 Genes Define Myeloma Cell Acquired Resistance to Bortezomib and Have Profound Prognostic Implications in Multiple Myeloma

Xenofon Papanikolaou, MD, Caleb K. Stein, MS, Ricky D Edmondson, PhD, Veronica Macleod, Ruslana Tytarenko, Bart Barlogie, MD PhD, Joshua Epstein, DSc, Christoph Heuck, MD
Journal: Blood
Blood (2015) 126 (23): 499.
https://doi.org/10.1182/blood.V126.23.499.499
Published: 2015
Journal Articles

Differential ICAM3 Gene Expression Correlates with Susceptibility to Natural Killer Cell-Mediated Lysis in Multiple Myeloma

Tarun K. Garg, PhD, Ricky D Edmondson, PhD, Shweta S. Chavan, PhD, Katie Stone, BS, Justin M Stivers, Jessica I Warden, Veronica Macleod, Charles M Skinner, Joshuah D Lingo, Amy D Greenway, Junaid Khan, Donald Johann, MD MS, Christoph Heuck, MD, Bart Barlogie, MD PhD, Gareth J Morgan, MDPhD, Joshua Epstein, DSc, Frits van Rhee, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2990.
https://doi.org/10.1182/blood.V126.23.2990.2990
Published: 2015
Journal Articles

Identifying Targets for Therapy in High Risk t(4;14) Myeloma Using Multi-Level Molecular and Phenotypic Analysis of Isogenic MMSET and MMSET Knock out Cell Lines

Charlotte Pawlyn, MB BChir, Tim Chambers, Veronica Macleod, Daniel Sappington, Amy Buros, PhD, Caleb K. Stein, MS, Martin F Kaiser, MD, Rosemary Burke, Swen Hoelder, Gunnar Boysen, Ricky D Edmondson, PhD, Gareth J Morgan, MD PhD, Faith E Davies, MD
Journal: Blood
Blood (2015) 126 (23): 1792.
https://doi.org/10.1182/blood.V126.23.1792.1792
Published: 2015
Journal Articles

Multiple Myeloma Cells Modulate ICAM-3 To Evade Natural Killer Cell-Mediated Lysis

Tarun K. Garg, PhD, Ricky D Edmondson, PhD, Shweta S. Chavan, PhD, Junaid Khan, PhD, Susann Szmania, BS, Justin Stivers, BS, Veronica Macleod, BS, Katie Stone, BS, Emily Woods, BS, Donald Johann, MD, MS, Bart Barlogie, MD, PhD, Joshua Epstein, DSc, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3105.
https://doi.org/10.1182/blood.V122.21.3105.3105
Published: 2013
Journal Articles

Proteomic Profiling of Multiple Myeloma: Correlation of Protein and Gene Expression Data.

Ricky D Edmondson, PhD, Sheeno P Thyparambil, Ph.D., Veronica MacLeod, Bart Barlogie, MD, PhD, John D. Shaughnessy, Jr., PhD
Journal: Blood
Blood (2008) 112 (11): 1705.
https://doi.org/10.1182/blood.V112.11.1705.1705
Published: 2008
Journal Articles

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

Yang Yang, Veronica MacLeod, Yuemeng Dai, Yekaterina Khotskaya-Sample, Zachary Shriver, Ganesh Venkataraman, Ram Sasisekharan, Annamaria Naggi, Giangiacomo Torri, Benito Casu, Israel Vlodavsky, Larry J. Suva, Joshua Epstein, Shmuel Yaccoby, John D. Shaughnessy, Jr, Bart Barlogie, Ralph D. Sanderson
Journal: Blood
Blood (2007) 110 (6): 2041–2048.
https://doi.org/10.1182/blood-2007-04-082495
Published: 2007
Journal Articles

Expression of Soluble Syndecan-1 or Heparanase by Myeloma Cells Enhances Levels of Angiogenic Growth Factors Present in Endothelial Cells.

Yang Yang, MD, PhD, Ashley Elizabeth Frith, Allison Theus, Veronica Macleod, MS, Ralph D. Sanderson, PhD
Journal: Blood
Blood (2006) 108 (11): 3448.
https://doi.org/10.1182/blood.V108.11.3448.3448
Published: 2006
Journal Articles

Extracellular Endosulfatases (Sulfs) Inhibit Myeloma Tumor Growth In Vivo .

Yuemeng Dai, MD, PhD, Yang Yang, MD, PhD, Veronica MacLeod, MS, Xinping Yue, PhD, Alan C. Rapraeger, PhD, Zachary Shriver, PhD, Ganesh Venkataraman, PhD, Ram Sasisekharan, PhD, Ralph D. Sanderson, PhD
Journal: Blood
Blood (2005) 106 (11): 3386.
https://doi.org/10.1182/blood.V106.11.3386.3386
Published: 2005
Journal Articles

Heparanase Upregulates Synthesis and Expression of Syndecan-1 (CD138) - A Novel Growth Regulatory Loop for Myeloma Tumors.

Yang Yang, MD, PhD, Veronica MacLeod, MS, Allison M. Theus, BS, Ralph D. Sanderson, PhD, Fenghuang Zhan, MD, PhD, John Shaughnessy, Jr., PhD
Journal: Blood
Blood (2005) 106 (11): 625.
https://doi.org/10.1182/blood.V106.11.625.625
Published: 2005
Journal Articles

Heparanase promotes the spontaneous metastasis of myeloma cells to bone

Yang Yang, Veronica MacLeod, Manali Bendre, Yan Huang, Allison M. Theus, Hua-Quan Miao, Paul Kussie, Shmuel Yaccoby, Joshua Epstein, Larry J. Suva, Thomas Kelly, Ralph D. Sanderson
Journal: Blood
Blood (2005) 105 (3): 1303–1309.
https://doi.org/10.1182/blood-2004-06-2141
Published: 2005
Journal Articles

Heparanase Promotes the Spontaneous Metastasis of Myeloma Cells to Bone.

Yang Yang, MD, PhD, Veronica MacLeod, MS, Manali Bendre, PhD, Yan Huang, Allison M. Theus, BA, Hua-Quan Miao, PhD, Paul Kussie, PhD, Shmuel Yaccoby, PhD, Joshua Epstein, DSc, Larry J. Suva, PhD, Thomas Kelly, PhD, Ralph D. Sanderson, PhD
Journal: Blood
Blood (2004) 104 (11): 635.
https://doi.org/10.1182/blood.V104.11.635.635
Published: 2004